EC
NGM
EcoR1 Capital’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,385,873
| Closed | -$2.05M | – | 65 |
|
|
2023
Q4 | $2.05M | Sell |
2,385,873
-4,049,645
| -63% | -$3.48M | 0.05% | 43 |
|
|
2023
Q3 | $6.89M | Hold |
6,435,518
| – | – | 0.23% | 37 |
|
|
2023
Q2 | $16.7M | Hold |
6,435,518
| – | – | 0.41% | 28 |
|
|
2023
Q1 | $26.3M | Hold |
6,435,518
| – | – | 0.85% | 18 |
|
|
2022
Q4 | $32.3M | Buy |
6,435,518
+5,894,410
| +1,089% | +$29.6M | 0.98% | 17 |
|
|
2022
Q3 | $7.08M | Hold |
541,108
| – | – | 0.21% | 40 |
|
|
2022
Q2 | $6.94M | Hold |
541,108
| – | – | 0.24% | 43 |
|
|
2022
Q1 | $8.25M | Buy |
+541,108
| New | +$8.25M | 0.26% | 45 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 86 |
|
|
2021
Q3 | – | Sell |
-143,567
| Closed | -$2.83M | – | 78 |
|
|
2021
Q2 | $2.83M | Hold |
143,567
| – | – | 0.11% | 49 |
|
|
2021
Q1 | $4.17M | Hold |
143,567
| – | – | 0.19% | 44 |
|
|
2020
Q4 | $4.35M | Buy |
+143,567
| New | +$4.35M | 0.23% | 43 |
|
|
2019
Q3 | – | Sell |
-316,900
| Closed | -$4.64M | – | 42 |
|
|
2019
Q2 | $4.64M | Buy |
+316,900
| New | +$4.64M | 0.47% | 30 |
|